American Journal of Transplantation · 2007 · 22 citations · 20 references
MedicineSurgeryCardiac TransplantationCardiothoracic SurgeryTransplant SurgeryCystic FibrosisLiver TransplantationLung TransplantationBilateral Lung TransplantationCystic Fibrosis Liver DiseasePost-transplant Immunosuppression
Sequential bilateral single lung‐liver transplantation (SBSL‐LTx) is a therapeutic option for patients with end stage lung and liver disease (ESLLD) due to cystic fibrosis (CF). A few cases have been reported, all of them were performed with the use of cardio‐pulmonary by‐pass (CPB). We performed SBSL‐LTx in three young men affected by CF. All the recipients had respiratory failure and portal hypertension with hypersplenism. Along with lung transplants, two patients received a whole liver graft and one an extended right graft from an in situ split liver. During transplantation neither CPB nor veno‐venous by‐pass (VVB) were employed. Immunosuppression was based on basiliximab, tacrolimus, steroids and azathioprine. The three recipients are alive with a median follow‐up of 670 days (range 244–1533). Combined SBSL‐LTx is a complex but effective procedure for the treatment of ESLLD due to CF, not necessarily requiring the use of CPB or VVB. Sequential bilateral single lung‐liver transplantation (SBSL‐LTx) is a therapeutic option for patients with end stage lung and liver disease (ESLLD) due to cystic fibrosis (CF). A few cases have been reported, all of them were performed with the use of cardio‐pulmonary by‐pass (CPB). We performed SBSL‐LTx in three young men affected by CF. All the recipients had respiratory failure and portal hypertension with hypersplenism. Along with lung transplants, two patients received a whole liver graft and one an extended right graft from an in situ split liver. During transplantation neither CPB nor veno‐venous by‐pass (VVB) were employed. Immunosuppression was based on basiliximab, tacrolimus, steroids and azathioprine. The three recipients are alive with a median follow‐up of 670 days (range 244–1533). Combined SBSL‐LTx is a complex but effective procedure for the treatment of ESLLD due to CF, not necessarily requiring the use of CPB or VVB.
20
Reversal of transplantation immunity by liver grafting
Naoshi Kamada, H. ff. S. Davies, Bruce Roser · Nature · 1981 · 277 citations
Life Sciences, Immunology, Surgery +14
Elbert P. Trulock, Leah B. Edwards, David O. Taylor et al. · The Journal of Heart and Lung Transplantation · 2006 · 270 citations
Medicine, Cardiology, Surgery +12
Paul Aurora, Leah B. Edwards, Anna Y. Kucheryavaya et al. · The Journal of Heart and Lung Transplantation · 2010 · 240 citations
Medicine, Pediatrics, Surgery +14